Yanwei Semiconductor, a company that excels in advanced ALD, PECVD, and specialized epitaxy equipment technologies, has triumphantly clinched nearly RMB 1.5 billion in Series B financing. This financing round drew strategic investments from key industry players, including the CETC Industrial Fund, along with contributions from prominent institutions such as CICC Capital. Notably, existing shareholders also further increased their stakes. Yanwei Semiconductor's product range spans multiple sectors, creating a comprehensive full-scenario product matrix and fostering a well-established supply chain. The capital raised will be earmarked for the iterative enhancement of core products, capacity expansion, and bolstering R&D efforts, with the overarching goal of cementing technological leadership and expediting the import substitution process. Dr. Lin Xing, the Chairman and CEO of the company, expressed that Yanwei Semiconductor will persist in its focus on product iteration and upgrades, diversifying its product offerings, and striving to emerge as a frontrunner in the industry, thereby supporting the sector in attaining self-sufficiency and enhanced control.